← Back to summaries

AMGN

AMGEN Inc
Healthcare · Drug Manufacturers - General · Data as of 2026-03-20
$346.37
SMA 20
SMA 50
SMA 200

📊 Valuation

Forward P/E14.8
Trailing P/E24.3
PEG Ratio4.23
Market Cap186.72B
Target Price$356.00

📈 Technicals

Trenddowntrend
RSI (14)35
Rel. Strength Rank72%
Above 50 SMA❌
Above 200 SMA✅

💰 Fundamentals

EPS (TTM)14.23
ROE106.10%
Profit Margin20.99%
Dividend9.66 (2.79%)

🎯 Strategy Analysis

Value Momentum 75 - PASS
  • Eligible asset class.
  • Intermediate trend does not confirm.
  • Liquidity clears threshold.
  • Price is above the 200 SMA.
  • Relative strength is supportive.
price-action 70 - WATCH
  • Eligible asset class for price action.
  • Clear market structure present.
  • Price at supply/demand zone.
  • No liquidity sweep detected.
  • Volume not confirming.
iron-condor 50 - FAIL
  • Eligible asset class for iron condor.
  • Live option-chain inputs unavailable.
  • Stock is trending - iron condor less ideal.
  • No earnings within DTE window.
  • Support and resistance levels defined for wing placement.
Covered Call / CSP 48 - FAIL
  • Eligible equity underlying.
  • No listed options available.
  • Underlying/options liquidity is acceptable.
  • Underlying is acceptable to own on assignment.
  • Support/resistance anchors exist for strike selection.
Bounce / Swing 35 - FAIL
  • Eligible equity for bounce/swing.
  • Trend context does not support bounce setup.
  • No pullback/consolidation pattern detected.
  • Support and resistance are defined.
  • Liquidity clears swing-trade threshold.